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Abstract
 .  .The purposes of this experiment were to: 1 , characterize the peptide aldehyde SJA6017, N- 4-fluorophenylsulfonyl -L-
 .valyl-L-leucinal, a newly synthesized inhibitor of calpain, and 2 test the effect of SJA6017 in preventing calcium
ionophore-induced cataract in cultured rat lenses. In vitro, SJA6017 strongly inhibited purified m-calpain from porcine
kidney. Casein zymography confirmed that SJA6017 reversibly bound to the active site of m-calpain. SJA6017 was also
confirmed to be a cell-permeable inhibitor in Molt-4 cells. In cultured lenses, SJA6017 reduced nuclear opacity and
proteolysis of crystallins and a-spectrin caused by calcium ionophore A23187. These results suggested that SJA6017 is a
reversible and cell-permeable calpain inhibitor which may possess great efficacy against calcium-induced models of
cataract. q 1997 Elsevier Science B.V.
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1. Introduction
 .Calpains EC 3.4.22.17 are non-lysosomal, cys-
teine proteases with a neutral pH optimum, and they
w xare activated by calcium 1 . Activated calpain is
thought to be involved in cataract formation in rodent
 .lenses for the following reasons: 1 Increased lens
calcium is found in many types of rodent cataracts
w x  .2–4 ; 2 the cleavage sites on the N-terminal exten-
sions on b-crystallins in insoluble lens proteins in
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cataractous rodent lenses are very similar to those
found on b-crystallin polypeptides incubated with
w x  .purified m-calpain 5,6 ; 3 inhibitors of cysteine
proteases such as calpain decreased proteolysis and
temporarily prevented the progression of cataract for-
mation caused by various inducers in vitro and in
w xvivo 7–9 .
A number of calpain inhibitors are reported in the
literature and these inhibitors were used in studies to
determine the role of calpain in disorders including
w xcataract 10 . The most widely used inhibitors are
probably the peptide aldehydes such as leupeptin.
The aldehyde end group binds the sulfhydryl group
of the active site cysteine to trap the enzyme. This
2q w xbinding is Ca dependent and reversible 10 . Unfor-
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tunately, cell permeability of leupeptin is low because
of the presence of the positively charged arginine
residue. Other widely used inhibitors are the epoxy-
succinyl peptides such as E64. This molecule cova-
lently binds to a critical sulfhydryl group in the active
w xsite of calpain, and this binding is irreversible 10 .
E64 prevents proteolysis of crystallins and temporar-
ily slows formation of nuclear cataract in vitro and in
vivo, although the membrane permeability of E64 is
w xrelatively poor 8 . However, the effect of E64 against
an in vivo animal model was weaker than against in
vitro lens culture system. We hypothesized that the
amount of E64 penetrating into the lens were not
high enough to prevent proteolysis of crystallins and
w xsubsequent opacity 7 . For more effective prevention
of cataract, a new peptide aldehyde inhibitor
 .SJA6017, N- 4-fluorophenylsulfonyl -L-valyl-L-leuci-
nal, offering stronger inhibition of calpain, or more
 .effective cell penetration, was synthesized Fig. 1 .
Thus, the purpose of the present experiment was to
test the efficacy of SJA6017 in prevention of proteol-
ysis of lens proteins and nuclear opacity in calcium
ionophore-induced cataract in cultured lenses. We
Fig. 1. Structures of calpain inhibitors used in the present study.
found that prevention of proteolysis and cataract by
SJA6017 were related to their strong inhibition of
calpain and extensive membrane permeability.
2. Materials and methods
2.1. Synthesis of SJA6017
Treatment of L-valine with 4-fluorobenzene-
 .sulfonyl chloride gave N- 4-fluorophenylsulfonyl -L-
valine which was coupled with L-leucinol by active
 .ester method to N- 4-fluorophenylsulfonyl -L-valyl-
L-leucinol. DMSO oxidation of N- 4-fluorophenyl-
.sulfonyl -L-valyl-L-leucinol using sulfur trioxide-
 .pyridine complex gave N- 4-fluorophenylsulfonyl -
 .L-valyl-L-leucinal SJA6017 . The compound synthe-
sized was confirmed by NMR and elemental analysis.
2.2. Enzyme assay
Calpain enzyme activity assays were performed
using FITC-labeled casein as substrate in a 30-min
w xassay at 308C 8 . Inhibition of calpain activity by
cysteine protease inhibitors was measured in the pres-
ence of 0.4 U of m-calpain purified from porcine
 .kidney Nacalai Tesque, Japan .
2.3. Proteolysis of a-crystallin and autolysis of m-
calpain
a-Crystallins were purified from rabbit lenses us-
w xing gel filtration chromatography 11 . Experimental
animals were handled in accordance with the Decla-
ration of Helsinki and appropriate National Institutes
of Health recommendations. Twelve units purified
m-calpainrml were incubated with 100 mgrml of
a-crystallin and 1.5 mM free calcium in buffer B
 .containing 50 mM Tris pH 7.4 , 1 mM EGTA, 3
mM dithiothreitol at 308C. The reaction was then
stopped by the addition of excess EDTA. To test for
inhibition of proteolysis of a-crystallin, 100 mM
SJA6017, 500 mM E64 Peptide Institute, Osaka
. Japan or 500 mM leupeptin Peptide Institute, Osaka
.Japan were used. SDS–PAGE of incubation mix-
w xtures was performed on discontinuous, 12% gels 12 .
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2.4. Casein zymography
Casein zymography was performed using the
w xmethod of Racer et al. 13 . Note that all zymograms
were soaked in the calcium buffer after electrophore-
sis so that calpain activity could be subsequently
visualized in the gels as lysis of casein. Pre-incubated
calpain samples were produced by incubating 12
units purified m-calpainrml with 1.5 mM calcium,
or without calcium, in buffer B at 308C. One hundred
mM SJA6017, 500 mM E64 or 500 mM leupeptin
were added to test for inhibition of m-calpain autoly-
sis. Calpain activity in the casein gels was visualized
by staining with Coomassie brilliant blue R-250,
yielding a white band indicating calpain proteolysis.
Experiments were also performed where calpain was
 .first incubated with calcium Fig. 4, lower , then after
subsequent zymography, no band of lysis was ob-
served because the calpain had degraded itself au-
.tolysis .
2.5. Molt-4 cell culture
To test the ability of inhibitors to permeate cell
membranes and to inhibit cellular calpain activity,
human lymphoid cell line MOLT-4 ATCC No. CRL
.1582 was used. Degradation of a-spectrin by m-
calpain in this cell line following treatment with
calcium ionophore A23187 has been well established
w x14 . MOLT-4 was subcultured as recommended by
American Type Culture Collection. Two million
MOLT-4 cellsrml were preincubated for 1 h with
inhibitors. To activate endogenous calpain, 5 mM of
calcium ionophore A23187 were added, and the cells
were further incubated for 1 h at 378C. Cells were
then collected by centrifugation and total cellular
protein for measurement of a-spectrin was extracted
w xas described 15 . Protein content was measured by
 .BCA assay Pierce Chemical Co., Rockford, IL us-
ing bovine serum albumin as a standard. Tricine
SDS–PAGE of total proteins were performed on
 . w xdiscontinuous, 10% gels Tefco, Japan 16 . Im-
munoblots for a-spectrin were performed by electro-
transferring proteins from SDS–PAGE gels onto
 .PVDF membrane Millipore using the method of
w x Towbin et al. 17 . A mouse anti-a-spectrin non-
. erythroid monoclonal antibody Chemicon Interna-
.tional Inc., CA was used at 1:500 dilution, and
immunoreactivity was visualized with alkaline phos-
phatase conjugated to anti-mouse IgG secondary anti-
 .body and BCIPrNBT Bio-Rad . The staining inten-
sity of the immunoblots of intact a-spectrin antigen
were determine by densitometric image analysis, since
the standard curves gave proportional increases in
a-spectrin staining as the amount of total protein
 .from MOLT-4 was increased data not shown .
Statistical analysis of data was performed by Dun-
nett multiple comparison.
2.6. Lens culture
For lens culture studies, lenses from 5-week-old
Sprague-Dawley rats were cultured at 378C under 5%
 .Fig. 2. Inhibition of purified m-calpain by E64 top , leupeptin
 .  .middle or SJA6017 bottom in vitro. Inhibitors were tested
against 0.4 U m-calpain in a caseinolytic assay. This is a repre-
sentative experiment repeated two times.
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 . Fig. 3. Representative SDS–PAGE measuring proteolysis of a-crystallins and autolysis of m-calpain with right gel and without left
. 2qgel Ca in incubation mixtures. Lanes marked ‘No-incubation’ are m-calpain and a-crystallins mixed but not incubated. Lanes marked
‘5 min-incubation’ are m-calpain and a-crystallins incubated for 5 min. Next lanes are incubated m-calpain and a-crystallins plus
 .inhibitors lanes marked ‘E64’, ‘SJA6017’ or ‘leupeptin’ for 5 min. Molecular weight standards are indicated in kDa on the left. Note
 .  .decreases in bands at approximately 80 kDa m-calpain 80-kDa subunit, solid arrow and 22 andror 24 kDa a-crystallins, solid arrows ,
 .  .and new bands at 43 kDa degraded calpain, stippled arrow and 19 kDa a-crystallin fragment, stippled arrow ; these changes were
prevented by E64, SJA6017 and leupeptin.
CO in 4 ml Eagle’s minimum essential medium2
 .  .MEM, Gibco with 10% fetal bovine serum Gibco
 .Normal group . This culture medium was used since
lens transparency could be maintained for at least 15
w xdays 18 . Ten mM calcium ionophore A23187 was
 .present on day 1 only A23187 group , and 100 mM
Fig. 4. Representative casein zymograms for m-calpain enzyme activity. Note that all zymograms were soaked in Ca2q buffer after
electrophoresis to show calpain activity remaining in the gel. This figure also shows results of an experiment were calpain solutions were
pre-incubated with or without Ca2q to test for autodegradation. White areas show caseinolysis at the active 80-kDa subunit of m-calpain.
 .  . 2qGels show caseinolytic activity of m-calpain after pre-incubation with lower and without upper Ca . Lanes marked ‘No-preincuba-
tion’ are m-calpain without pre-incubation. Lanes marked ‘5 min-preincubation’ are m-calpain pre-incubated for 5 min. Next lanes are
 .pre-incubated m-calpain plus inhibitors lanes marked ‘E64’, ‘SJA6017’ or ‘Leupeptin’ for 5 min. Last 4 lanes are pre-incubated
 .  .  .m-calpain plus E64 lanes marked ‘E64rLeupeptin’ , leupeptin lanes marked ‘LeupeptinrE64’ , E64 lanes marked ‘E64rSJA6017’ or
 .SJA6017 lanes marked ‘SJA6017rE64’ for 5 min followed by leupeptin, E64, SJA6017 or E64 for an additional 5 min.
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SJA6017, E64 or leupeptin were present continuously
 .AqSJA6017, E64 or leupeptin group, respectively .
After 5 days of culture, lenses were photographed
under a dissecting microscope, and density of lens
opacity was quantitated using computerized image
analysis Image 1.31 software, Twilight clone BBC,
.Silver Springs, MD . After homogenization, soluble
and insoluble proteins were obtained by centrifuga-
w xtion 8 , and protein contents were measured by BCA
assay. SDS–PAGE of proteins were performed on
w xdiscontinuous, 12% gels 12 . The staining intensity
of gels was measured using densitometric image
analysis, and breakdown of a-crystallin in the soluble
proteins was used as a marker for proteolysis because
a-crystallin is lost in rat lenses cultured with cataract-
w xgenic agents 8 . Immunoblots for a-spectrin of solu-
ble and insoluble proteins were performed using the
same protocol as MOLT-4 cells. For analysis of
crystallins and a-spectrin, whole lenses were used
although the opacities of lenses were mainly in the
nucleus. Crystallins and a-spectrin are distributed in
w xcortex and nucleus of the lens 19 , and proteolysis of
w xcrystallins was found in both regions 20 .
3. Results and discussion
The three compounds tested inhibited purified m-
 .calpain in a concentration-dependent manner Fig. 2 .
SJA6017 was the most effective with an IC values50
of 0. 08 mM.
In vitro incubation of a-crystallins with m-calpain
and Ca2q caused a decrease in intact a-crystallin
polypeptides along with the accumulation of new,
lower molecular weight fragments at approximately
 .19 kDa Fig. 3, right . The 80-kDa subunit of m-
calpain also decreased as incubation time with Ca2q,
and a 43-kDa fragment of m-calpain appeared Fig.
.3, right . In contrast, when a-crystallins and m-
calpain were incubated without Ca2q, no proteolysis
 .was observed Fig. 3, left . SJA6017, E64, and leu-
peptin all inhibited proteolysis of a-crystallins and
 .the decrease in 80-kDa m-calpain Fig. 3, right .
Casein zymograms showed that the band at 80 kDa
representing m-calpain enzyme activity decreased due
to autolysis during pre-incubation for 5 min with
2q  .Ca Fig. 4, lower . The band of m-calpain activity
did not decrease when the pre-incubation solution did
2q  .not contain Ca Fig. 4, upper . Note that no de-
crease in m-calpain activity occurred because the
original incubation before zymography contained no
Ca2q, and calpain activation and subsequent au-
todegradation did not occur. All zymograms were
then soaked in buffer with Ca2q to reveal remaining
calpain enzyme activity. Binding of calpain inhibitors
to m-calpain was assessed by visualizing white bands
at 80 kDa on casein gels as a maker of remaining
calpain activity after pre-incubation. Appearance of
white bands on casein gels indicated that inhibitors
were reversible, because the inhibitors were removed
 .Fig. 5. Representative immunoblot upper and densitometric
 .  .image analysis lower for a-spectrin in total protein 25 mgrlane
from cultured MOLT-4 cells showing proteolysis of a-spectrin
after A23187 treatment and inhibition by calpain inhibitors. Cells
 .were cultured without Normal or with A23187; or with A23187
 .  . plus E64 AqE64 , leupeptin Aqleupeptin or SJA6017 Aq
.SJA6017 . Molecular weight standards are indicated in kDa on
the left. Note decreases in bands at approximately 280 kDa for
 .a-spectrin solid arrow , and new bands at 145 and 150 kDa
 .stippled arrows ; these changes were partially prevented by
SJA6017 and leupeptin, although SJA6017 was more effective
 .than leupeptin. Data are means"S.D. ns5 . ) P -0.01 rela-
tive to Normal and )) P -0.05 relative to A23187.
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from m-calpain by electrophoresis. On the other hand,
lack of white bands on casein gels indicated that
inhibitors were irreversible; they were not removed
from m-calpain after electrophoresis because of cova-
lent binding between calpain and the irreversible
inhibitor. When pre-incubations with Ca2q included
the irreversible inhibitor E64, m-calpain enzyme ac-
tivity was inhibited. The band of m-calpain activity
was not inhibited by E64 when Ca2q was absent
from the pre-incubation solution. This result showed
that E64 irreversibly bound to m-calpain only when
Ca2q was present. Without Ca2q, E64 could not bind
to m-calpain in the initial incubation, and caseinoly-
sis occurred during Ca2q development of the zymo-
gram once E64 was removed by electrophoresis. In
contrast, m-calpain was reversibly inhibited by leu-
peptin. The band of m-calpain activity visualized in
the zymogram was not decreased by pre-incubation
with leupeptin and Ca2q. Electrophoresis removed
the reversible calpain inhibitor leupeptin, and ca-
seinolysis could be observed in the zymogram. This
indicated that, in contrast to E64, leupeptin was
reversibly bound to m-calpain. When m-calpain was
pre-incubated with leupeptin before m-calpain was
further inactivated by E64, the band of m-calpain
activity was not decreased. Leupeptin could preoc-
cupy the active site and E64 no longer bound to
active site of m-calpain. Results with SJA6017 were
very similar to the reversible calpain inhibitor leu-
peptin. The band of m-calpain activity visualized in
the zymogram was not decreased by pre-incubation
with SJA6017 and Ca2q. Thus, SJA6017 bound to
the active site of calpain as E64. However, binding of
SJA6017 was reversible in contrast to the irreversible
inhibitor E64. Reversible inhibitors allow recovery of
enzyme activity by dissociation, even though re-
versible inhibitors bind to non-target enzymes ini-
w xtially 21 . This may be produce fewer side-effects
because none of calpain inhibitors reported in the
literature are highly selective for calpain. That is,
most calpain inhibitors cross react with other cysteine
w xproteases such as cathepsins 22 .
In cultured MOLT-4 cells, treatment with A23187
caused a decrease in intact a-spectrin at approxi-
Fig. 6. Representative photomicroscopy of calcium ionophore-induced cataract and inhibition by calpain inhibitors on day 5 of culture.
Darker areas are cataracts in these backlit lenses. Insert bar graph shows increased density of nuclear opacity in cultured lenses treated
 .with calcium ionophore and reduction of opacity by calpain inhibitors. Data are means"S.D. ns5 . ) P-0.01 relative to Normal
and )) P-0.01 relative to A23187 alone and Aq leupeptin.
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mately 280 kDa along with the accumulation of new,
lower molecular weight fragments at 145 and 150
 .kDa Fig. 5, upper . These two fragments are pro-
w xduced sequentially 14 . Note that SJA6017 and leu-
peptin partially prevented proteolysis of a-spectrin
and inhibited production of the 145-kDa fragment.
E64 did not inhibit proteolysis of a-spectrin and
production of the 145-kDa fragment. Measurement of
280-kDa intact a-spectrin bands by image analysis
confirmed that SJA6017 was more effective than
 .leupeptin Fig. 5, lower . This suggested that SJA6017
was more cell permeable than leupeptin or E64,
because SJA6017 was able to prevent breakdown of
a-spectrin more effectively. However, calpain in-
hibitors used in this study did not completely inhibit
proteolysis of a-spectrin since a 150-kDa a-spectrin
fragment appeared. One possible reason for this result
is that the cleavage site of a-spectrin to produce the
w x150-kDa fragment is highly sensitive to protease 23 .
The other possibility is that the ICE family of pro-
teases also produced a 150-kDa a-spectrin fragment
which was nearly identical to calpain-produced 150-
kDa fragment in electrophoretic mobility, although
w xboth fragments have different N-termini 24 .
Lenses cultured for 5 days in MEM remained clear
 .and appeared similar to fresh lenses Fig. 6 . The
toxic effect of SJA6017 on lens cultures was first
assessed. The appearance of lenses cultured with
SJA6017 alone was similar to fresh lenses data not
.shown . Addition of 10 mM A23187 during the first
day of culture caused a hazy opacity to appear in the
peripheral region and a dense opacity in the central
region of the lens by day 5 of culture. The effective-
ness of the inhibitors in preventing these opacities
was tested. Fig. 6 shows the typical appearance of
A23187-treated lenses following culture with calpain
inhibitors. SJA6017 and E64 were able to protect
lenses against calcium ionophore-induced nuclear
cataract. On the other hand, leupeptin did not reduce
nuclear opacity. Measurement of the mean density of
nuclear opacity in the lenses by image analysis con-
firmed the effect of inhibitors Fig. 6, insert bar
.graph .
Analysis of the constituent polypeptides in the
soluble fraction of normal lenses by SDS–PAGE
revealed a characteristic predominance of poly-
peptides belonging to lens crystallins in the molecular
weight range of 19–31 kDa Fig. 7, upper, lane
Fig. 7. Representative SDS–PAGE of soluble proteins 5
.  .mgrlane from lenses upper and densitometric image analysis
 .for 20-kDa a-crystallin polypeptide lower . Molecular weight
standards are indicated as kDa on left. In cataractous lenses, note
 .decrease of bands at approximately 31 and 20 kDa solid arrows ,
 .and new bands at 27 and 18 kDa stippled arrows ; these changes
were prevented by E64 or SJA6017. Data are means"S.D.
 .ns5 . ) P -0.01 relative to Normal, )) P -0.01 relative to
A23187 alone and Aqleupeptin.
.Normal . A23187-induced cataract exhibited proteol-
 .ysis of crystallins Fig. 7, upper, lane A23187 . For
example, the 31-kDa b- and 20-kDa a-crystallins
were decreased, along with the accumulation of new
polypeptide bands at approximately 27 kDa and 18
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 .  .Fig. 8. Representative immunoblots for a-spectrin in the insoluble proteins 40 mgrlane from lenses cultured for 1, 3 and 5 days left
 .and densitometric scanning of immunoblots from lenses cultured for 5 days right . Insoluble protein from normal lenses contained
 .  .a-spectrin at approximately 280 kDa solid arrow and 145- and 150-kDa a-spectrin fragments stippled arrows . Insoluble protein in
cultured lenses with A23187 showed decrease in band for a-spectrin at approximately 280 kDa, and increased-bands at 145 and 150 kDa
by 1 day. The 150-kDa fragment then decreased and the 145-kDa fragment increased by day 3. SJA6017 and E64 partially prevented
theses changes.
kDa. This is a typical pattern resulting from proteoly-
w xsis by calpain 7,8 . Treatment with SJA6017 or E64
reduced proteolysis of crystallins observed in cataract
induced by A23187, while leupeptin did not prevent
 .proteolysis Fig. 7, upper . Measurement of the a-
crystallin band in the gels by image analysis con-
 .firmed the effect of inhibitors Fig. 7, lower . A
positive relationship between inhibition of nuclear
opacity and inhibition of proteolysis by calpain in-
hibitors in cultured lenses was observed.
Proteolysis of spectrin and inhibition by cell per-
w xmeable calpain antagonists have been reported 9 .
 .Insoluble protein from fresh non-cultured lens con-
tained intact a-spectrin and lower molecular weight
fragments at 145 and 150 kDa; their concentrations
were not changed when lenses were cultured in nor-
mal medium for 5 days Fig. 8, left; lanes Fresh
.versus Normal . Intact a-spectrin in the lens insolu-
ble fraction decreased in A23187-induced cataract,
and lower molecular weight fragments at 145 and
150 kDa increased by 1 day Fig. 8, left; lane
.A23187 . The 150-kDa fragment then decreased and
the 145-kDa fragment increased by day 3. This prote-
olysis increased with culture time. SJA6017 and E64
partially prevented the decrease in intact a-spectrin
and 150-kDa fragment, and the increase in the 145-
 .kDa fragment Fig. 8, left . Leupeptin did not prevent
proteolysis of a-spectrin observed in the cataractous
lenses. Measurement of each band in the blots by
image analysis confirmed the effect of inhibitors Fig.
.8, right . Similar result was observed in soluble pro-
 .tein from cultured lenses data not shown .
In summary, the studies above report a new, re-
versible, cell-permeable calpain inhibitor, SJA6017,
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which may possess great efficacy against calcium-in-
duced models of rodent cataracts. Results of this
experiment suggest future studies to test if SJA6017
is effective in reducing some of pathology associated
with cataract in rodent models. The hope is that
someday it may be possible to test if SJA6017 is
beneficial in preventing some of the pathology in
human cataract.
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